Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The usual result of breaking a heel is you fall down.;)
Like I said.
JJ is scheduled to speak tomorrow at 1010.
Well it was fun while it lasted! We look set to give back some, if not most, of the gains from yesterday.
I find it worrying. All the numbers vf posted are correct and nrx's typical aftermarket and premarket trade is usually a few hundred shares or less.
I think speculation regarding UK approval is based on their (nih) stated desire to be a leader in approval of groundbreaking new drugs. I don't think it's anything other than that and as such is pure speculation. Could be wrong though.
NRX could easily make a new 52 week low today. There's absolutely no enthusiasm for NRX or RLFTF at this point.
Someone mentioned recently that the stock would fill the gap at $1.30 and that's where we are. My question is "are we done yet"? Any more gaps to fill below 1.30?
I hope to live long enough to see it. ;)
And they're listed on the nasdaq. They went up today but they were down 16% yesterday and they've drifted lower since their listing. No need to envy them. They're still in the same boat we are.
I've seen this twice before in the last few months. Sharp drop followed by a quick recovery so assume it was manipulaters. Hope that's true this time too.
We're at 1.31. What's the bad news?
Maybe not.
I considered your post as reasonable until your claim to still be holding shares. If you're certain of your claim there's absolutely no reason for you to continue holding shares.
For some reason I thought this test had been underway for a few weeks. Guess that was the recruiting stage.
Yeah, up nearly 20% this morning and down nearly 20% to a $9.50 low. A few cents away from a new 52 week low. 2 million shares traded which is a significant percentage of the float.
Insane.
Nrxp up 20% on 250% of avg volume. Looks like all the eua speculation is there. None here. It's good to be listed on a major exchange.
Nrxp was up 17% on twice normal volume yesterday. Just sayin'
For those posting regarding FDA and big pharma influence, this just happened.
FDA chief calls for probe of talks between agency and Biogen before Alzheimer's drug was approved
https://www.google.com/amp/s/www.cbsnews.com/amp/news/biogen-alzheimers-drug-fda-investigation-doctors/
Why wouldn't they take another vaccine? Other than the fact that it will be like the current vaccines, untested. People routinely take flu vaccines on an annual basis so this should be no different for those who have already taken the covid jab.
NRX established a new 52 week low this morning.
The volume doesn't support a leak either good or bad.
My original comment was in reply to a post commenting on the use of technical analysis in regard to this stock. Frankly, I think it doesn't apply to this stock at all except on a day to day basis absent news, good or bad. This will rocket up or drop like a stone on news. Since I'm still invested here, and underwater at the moment, I'm betting on the former based on the science as best I understand it.
Every stock I own, including this one, moved in concert with the market yesterday.
If we bounce back I dont think it will be today with the market set to open about 1.5% lower. We'll see 1.35 today, possibly lower.
It's a polisci board apparently. Split equally between the two.
I was under the (wrong) impression it had already begun.
I occasionally check to see if it's been approved in India yet even though it wouldn't be beneficial to rlftf or nrxp. The drug is already being used on the Caucasus.
I'm not familiar with that varietal.
Been there. Beautiful city. Excellent movie too.
Do they have patent(s) for direct yet? There was discussion on the board recently about a patent application being rejected with a request for more detail but IIRC it was only the most recent and NWBO possesses several patents for direct.
Based on what I'm reading on Yahoo rlf is setting the stage for an announcement by creating an ad hoc announcement format iaw Swiss law to ensure insiders do not get relevant information before retail investors do.
I'm actually hoping NWBO gets bought by big pharma. I learned a harsh lesson in amrn and I don't want to experience that again.
While crl has been on a buying spree recently their wheelhouse is contract manufacturing and research services, not retail pharma.
You need to be realistic about this. It's a press release only investors already in rlftf will see and it's just the culmination of a deal announced months ago. The market has already digested this news. The only thing that counts as far as moving the share price here is whether or not we get the eua.
It's just the finalizing of a deal announced months ago.
Since the WHO separated idh mutations from gbm this year and our data lock was last year is it even possible to separate the idh patients even if that results in better more reliable data?
Exactly. And your last para is biblical.
Vaccination may be voluntary but some universities and some entertainment venues are making it mandatory. So, yes, it is voluntary but you may be shut off from society and I expect the pressure to get the vaccine will intensify.